Kanativa USA Inc. 4
4 · NEXIEN BIOPHARMA, INC. · Filed May 1, 2019
Insider Transaction Report
Form 4
Intiva USA Inc
10% Owner
Transactions
- Sale
Common Stock
2019-04-04$0.09/sh−5,000,000$425,000→ 19,000,000 total
Footnotes (2)
- [F1]The Reporting Person sold 5,000,000 shares effective April 4, 2019.
- [F2]In exchange for the sale of the 5,000,000 shares of common stock, the Reporting Person received 8,500,000 shares of common stock of Phyto Brands Inc., which valued the shares of Nexien BioPharma Inc. at $0.085 per share.